Cite
Risk-Adapted Treatment Strategies with Pre-Irradiation Chemotherapy in Pediatric Medulloblastoma: Outcomes from the Polish Pediatric Neuro-Oncology Group.
MLA
Perek-Polnik, Marta, et al. “Risk-Adapted Treatment Strategies with Pre-Irradiation Chemotherapy in Pediatric Medulloblastoma: Outcomes from the Polish Pediatric Neuro-Oncology Group.” Children (Basel, Switzerland), vol. 10, no. 8, Aug. 2023. EBSCOhost, https://doi.org/10.3390/children10081387.
APA
Perek-Polnik, M., Cochrane, A., Wang, J., Chojnacka, M., Drogosiewicz, M., Filipek, I., Swieszkowska, E., Tarasinska, M., Grajkowska, W., Trubicka, J., Kowalczyk, P., Dembowska-Bagińskai, B., & Abdelbaki, M. S. (2023). Risk-Adapted Treatment Strategies with Pre-Irradiation Chemotherapy in Pediatric Medulloblastoma: Outcomes from the Polish Pediatric Neuro-Oncology Group. Children (Basel, Switzerland), 10(8). https://doi.org/10.3390/children10081387
Chicago
Perek-Polnik, Marta, Anne Cochrane, Jinli Wang, Marzanna Chojnacka, Monika Drogosiewicz, Iwona Filipek, Ewa Swieszkowska, et al. 2023. “Risk-Adapted Treatment Strategies with Pre-Irradiation Chemotherapy in Pediatric Medulloblastoma: Outcomes from the Polish Pediatric Neuro-Oncology Group.” Children (Basel, Switzerland) 10 (8). doi:10.3390/children10081387.